• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[癌性渗出物中存在的半胱氨酸蛋白酶抑制剂对肿瘤特异性组织蛋白酶B的调节作用]

[Regulation of neoplasm-specific cathepsin B by cysteine-protease inhibitors present in cancerous exudates].

作者信息

Keppler D, Pagano M, Dalet-Fumeron V, Engler R

出版信息

C R Acad Sci III. 1985;300(13):471-4.

PMID:3924358
Abstract

The Cathepsin B-like proteinase, a secretory form of lysosomal cathepsin B, is present in some cancerous exudates (i.e. pleural and ascitic fluids). It has been suggested that this enzyme may be involved in the invasive process, one of the most important aspects of cancer pathology. In the same fluids, two kinds of cysteine-proteinase inhibitors (C.P.I.'s) are found- HMr-CPI (90,000 daltons) and LMr-CPI's (11,000-13,000 daltons). The Cathepsin B-like enzyme is more strongly inhibited by the LMr-CPI's than by the HMr-CPI, the Ki values are 4.0 X 10(-9) M and 1.2 X 10(-7) M respectively. Theses results underline the similarity between this enzyme and the lysosomal Cathepsin B. On the other hand, the inhibitors could play a protective role against tumor invasion.

摘要

组织蛋白酶B样蛋白酶是溶酶体组织蛋白酶B的一种分泌形式,存在于一些癌性渗出液中(即胸水和腹水)。有人提出,这种酶可能参与侵袭过程,这是癌症病理学最重要的方面之一。在相同的液体中,发现了两种半胱氨酸蛋白酶抑制剂(C.P.I.)——HMr-CPI(90,000道尔顿)和LMr-CPI(11,000 - 13,000道尔顿)。组织蛋白酶B样酶受LMr-CPI的抑制作用比受HMr-CPI的抑制作用更强,其Ki值分别为4.0×10⁻⁹ M和1.2×10⁻⁷ M。这些结果强调了这种酶与溶酶体组织蛋白酶B之间的相似性。另一方面,这些抑制剂可能对肿瘤侵袭起到保护作用。

相似文献

1
[Regulation of neoplasm-specific cathepsin B by cysteine-protease inhibitors present in cancerous exudates].[癌性渗出物中存在的半胱氨酸蛋白酶抑制剂对肿瘤特异性组织蛋白酶B的调节作用]
C R Acad Sci III. 1985;300(13):471-4.
2
An inactive cathepsin B-like enzyme and cysteine proteinase inhibitors in colon cancer ascites.结肠癌腹水中的一种无活性的组织蛋白酶B样酶和半胱氨酸蛋白酶抑制剂。
Neoplasma. 1992;39(2):107-14.
3
Expression of high molecular weight cysteine proteinase inhibitor in ovarian cancer tissues: regulation of cathepsin B expression by placental CPI.
Biol Chem. 2003 Jul;384(7):1103-7. doi: 10.1515/BC.2003.123.
4
Purification and characterization of two different precursor forms of the cathepsin B-like proteinase from human malignant ascitic fluid.
Biol Chem Hoppe Seyler. 1988 May;369 Suppl:185-90.
5
Characterization of cathepsin B-like proteinase from ascitic fluid of patients with primary liver cancer.
Neoplasma. 1984;31(5):581-90.
6
Sensitization to the lysosomal cell death pathway upon immortalization and transformation.永生化和转化过程中对溶酶体细胞死亡途径的致敏作用。
Cancer Res. 2004 Aug 1;64(15):5301-10. doi: 10.1158/0008-5472.CAN-04-1427.
7
[Characterization of cysteine proteinase endogenous inhibitors obtained from transformed fibroblasts].
Vopr Med Khim. 2002 Nov-Dec;48(6):611-7.
8
[Digestion in vitro of basal membrane, bovine lens capsule, by human liver lysosome cathepsins B, H and L and ascitic fluid tumor cathepsin B from ovarian adenocarcinoma].[人肝脏溶酶体组织蛋白酶B、H和L以及来自卵巢腺癌的腹水肿瘤组织蛋白酶B对牛晶状体囊基底膜的体外消化作用]
Pathol Biol (Paris). 1990 Dec;38(10):988-92.
9
Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors.木瓜蛋白酶样半胱氨酸蛋白酶及其蛋白质抑制剂的结构与功能方面
Biol Chem. 1997 Mar-Apr;378(3-4):141-50.
10
Invasion of ras-transformed breast epithelial cells depends on the proteolytic activity of cysteine and aspartic proteinases.Ras 转化的乳腺上皮细胞的侵袭依赖于半胱氨酸蛋白酶和天冬氨酸蛋白酶的蛋白水解活性。
Biol Chem. 2001 May;382(5):853-7. doi: 10.1515/BC.2001.104.

引用本文的文献

1
Purification and characterization of a newly serine protease inhibitor from Rhamnus frangula with potential for use as therapeutic drug.从鼠李中纯化和鉴定一种新型丝氨酸蛋白酶抑制剂,其有潜力用作治疗药物。
3 Biotech. 2017 Jun;7(2):148. doi: 10.1007/s13205-017-0764-z. Epub 2017 Jun 8.
2
Protease inhibitor from Moringa oleifera with potential for use as therapeutic drug and as seafood preservative.辣木蛋白酶抑制剂具有作为治疗药物和海鲜防腐剂的潜力。
Saudi J Biol Sci. 2011 Jul;18(3):273-81. doi: 10.1016/j.sjbs.2011.04.002. Epub 2011 Apr 18.